CHOs Flashcards
General structures of CHOs, including formula
Composed of carbon, hydrogen, and oxygen in ratio of 1:2:1
- (CH2O)n
What contains 3,4,5,6 or more carbon atoms
Monosaccharides
Two monosaccharides linked together w/ the loss of a molecule of water
Disaccharides
Composition of lactose
Glucose + galactose
Composition of maltose
Glucose + glucose
Composition of sucrose
Glucose + fructose
Composition of glycogen
Multiple branches of glucose chains
Reagent used to detect “reducing sugars”
Benedict’s reagent
Composition of starch
Amylose and amylopectins (grains and starchy vegetables)
Significance of a positive test for reducing sugars
Galactose isn’t detected by a dipstick
- Therefore, if urine is negative for glucose w/ a dipstick but is positive w/ a Clinitest, they have galactose in urine (galactosemia)
Two analogically important reducing sugars
Glucose and galactose
Carb digestion
- Where does starch digestion begin and the enzyme responsible?
In the mouth by salivary amylase
Digestion of starch due to ____ ____ in the intestine
Pancreatic amylase
Four enzymes responsible for intestinal digestion
Lactase, maltase, sucrase, and galactase
What organ do these metabolic pathways occur in and specific starting and ending products
- Glycolysis (anaerobic and aerobic)
Breakdown of glucose (glucose → lactate ↔ pyruvate)
- Anaerobic: glucose → lactate/RBCs and skeletal muscle
- Aerobic: pyruvate → acetyl CoA/mitochondria
What organ do these metabolic pathways occur in and specific starting and ending products:
- Glycogenesis
Making glycogen (glucose-1-phosphate → glycogen)
- Occurs when there’s a decrease in blood glucose concentration
What organ do these metabolic pathways occur in and specific starting and ending products
- Kreb’s cycle (oxidative phosphorylation)
??
- Pyruvate → acetyl CoA → ATP, CO2, water
- Occurs in the mitochondria
What organ do these metabolic pathways occur in and specific starting and ending products:
- Glycogenolysis
Breaking down glycogen
- Glycogen → glucose-1-phosphate → glucose
- Occurs in muscle and liver tissues during a time of fasting
What organ do these metabolic pathways occur in and specific starting and ending products:
- Gluconeogenesis
Making new glucose from non-CHO sources
non-CHO sources → glucose
(non-CHO sources are amino acids, lactate, glycerol, and fatty acids)
- Occurs in the liver
What organ do these metabolic pathways occur in and specific starting and ending products:
- Hexose monophosphate pathway
??
- Glucose-6-phosphate → ribose + CO2
- Occurs in the liver
Specific site of production of insulin
Beta cells of islets of Langerhans of pancreas
Function of C-peptide
To ensure correct structure of insulin
Function of proinsulin
Storage form of insulin
General effect of insulin on blood glucose concentration
Decrease
Four specific anabolic effects of insulin
↑ glycogenesis
↑ lipid synthesis (esp. triglycerides and cholesterol)
↑ glycolysis
↑ amino acid synthesis
Action of insulin on cell membranes and resultant effect on blood sugar levels
↑ in cell membrane permeabilty to glucose
↓ in blood levels of glucose
Specific effects of insulin on cells in the liver
Liver: INHIBITS glycogenolysis and gluconeogenesis and STIMULATES glycogenesis and fatty acid synthesis
Two specific catabolic effects of insulin
↓ hepatic glycogenolysis and gluconeogenesis
Major factor that regulates the release of insulin
Blood glucose concentration
- Insulin is released from pancreas when circulating blood glucose is increased
Specific site of glucagon production
Secreted by alpha cells of pancreatic islets of Langerhans
General effect of glucagon on blood glucose concentration
↑ blood glucose
Two specific glucose metabolism effects of glucagon
- Stimulates glycogenolysis and gluconeogenesis to increase glucose
- Inhibits glucose-consuming pathways in the liver
Major factor that regulates teh release of glucagon
Secreted when glucose is decreased
General effect on blood glucose concentration (increase or decrease) of:
- Growth hormone
Increased
General effect on blood glucose concentration (increase or decrease) of:
- Epinephrine
Increased
General effect on blood glucose concentration (increase or decrease) of:
- Adrenocorticotrophic hormone (ACTH)
Increased
General effect on blood glucose concentration (increase or decrease) of:
- Cortisol
Increased
General effect on blood glucose concentration (increase or decrease) of:
- Thyroxine (T4)
Increased
General effect on blood glucose concentration (increase or decrease) of:
- Somatostatin
↑ glucose
- Secreted by delta cells of pancreatic islets of Langerhans; inhibit both glucagon and insulin from pancreas (which ↓ glucose)
- Can also inhibit growth hormone release (which ↑ glucose)
General effect on blood glucose concentration (increase or decrease) of:
- Somatomedins
↓ glucose
- produced in liver in response to stimulation by growth hormone
Hyperglycemia blood sugar value
Glucose > 100 mg/dL
Hypoglycemia blood sugar value in adults
Glucose < 50 mg/dL
Three specific diagnostic criteria for diabetes mellitus and specific laboratory values associated w/ the diagnostic criteria
- Fasting blood glucose > 126 mg/dL
- 2 hour post-parandial (2 HPP) glucose > 200 mg/dL during OGTT
- Clinical symptoms and random glucose > 200 mg/dL
Nine complications of diabetes
- Nephrophy (renal failure)
- Neuropathy (impaired sensation of feet)
- Heart disease and stroke
- Hypertension
- Blindness and retinopathy
- Amputations
- Dental disease
- Complications of pregnancy (birth defects, spontaneous abortion, excessively large baby)
- Life-threatening events
Four clinical symptoms used in the diagnosis of diabetes mellitus
- Polyuria
- Polyphagia
- Polydipsia
- Unexplained weight loss
One specific cause of Type 1 diabetes mellitus
Beta cell destruction
Five causes of beta cell injury in diabetes mellitus
- Genetic factors (HLA Ags on chromosome 6)
- Environmental factors
- Viral causes (measles, mumps, EBV, etc.)
- Chemical causes
- Autoimmune disease (85-90% of cases have detectable Abs)
Relative insulin concentration in Type 1 diabetes mellitus
Decreased to absent insulin (absolute insulinopenia)
Three general metabolic changes in Type 1 diabetes mellitus
- Inhibition of glycolysis
- Increased glycogenolysis, lipolysis, and gluconeogenesis
- Increased levels of acetyl CoA, converted to ketone bodies
Treatment of Type 1 diabetes mellitus
Administration of exogenous insulin injections
Type 2 diabetes mellitus
- 8 factors that predispose patients for the disease
- Older age (> 40 years old)
- Obesity (BMI > 30)
- Family history
- Sex (females more prevalent than males)
- History of gestational diabetes
- Impaired glucose metabolism
- Physical inactivity
- Race/ethnicity
Type 2 diabetes mellitus
- Two specific causes of the disease
Insuline resistance and beta cell failure
Type 2 diabetes mellitus
- Two factors that may predispose a patient to develop the disease
Genetic factors (stronger tendency than in Type 1) and environmental factors (obesity or increased caloric intake)
Type 2 diabetes mellitus
- Relative insulin concentrations
Variable (depends on cause and severity of disease)
Type 2 diabetes mellitus
- Treatment
- Weight loss
- Dietary changes
- Oral hypoglycemia agents (Glucophage)
A form of glucose intolerance diagnosed in some women during pregnancy
Gestational diabetes mellitus (GDM)
Possible long term effect of GDM
Women who had gestational diabetes have 35-60% chance of developing diabetes in the next 10-20 years